Wellington Management Group
TARO

Wellington Management Group’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Wellington Management Group’s Portfolio TARO Stock Details TARO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-4,597
Closed -$340K – 2282
2021
Q1 		$340K Sell
4,597
-2,383
-34% -$181K ﹤0.01% 1955
2020
Q4 		$513K Sell
6,980
-7,390
-51% -$475K ﹤0.01% 1711
2020
Q3 		$788K Sell
14,370
-8,602
-37% -$535K ﹤0.01% 1609
2020
Q2 		$1.53M Sell
22,972
-9,166
-29% -$615K ﹤0.01% 1399
2020
Q1 		$1.97M Sell
32,138
-5,023
-14% -$372K ﹤0.01% 1361
2019
Q4 		$3.27M Buy
37,161
+666
+2% +$56.2K ﹤0.01% 1434
2019
Q3 		$2.75M Hold
36,495
– – ﹤0.01% 1501
2019
Q2 		$3.12M Sell
36,495
-2,619
-7% -$259K ﹤0.01% 1507
2019
Q1 		$4.23M Sell
39,114
-1,268
-3% -$126K ﹤0.01% 1417
2018
Q4 		$3.42M Hold
40,382
– – ﹤0.01% 1488
2018
Q3 		$3.97M Sell
40,382
-11,814
-23% -$1.28M ﹤0.01% 1537
2018
Q2 		$6.04M Sell
52,196
-3,670
-7% -$403K ﹤0.01% 1431
2018
Q1 		$5.52M Hold
55,866
– – ﹤0.01% 1451
2017
Q4 		$5.85M Sell
55,866
-2,707
-5% -$297K ﹤0.01% 1430
2017
Q3 		$6.6M Sell
58,573
-28,768
-33% -$3.13M ﹤0.01% 1395
2017
Q2 		$9.79M Sell
87,341
-47,159
-35% -$5.33M ﹤0.01% 1218
2017
Q1 		$15.7M Sell
134,500
-55,453
-29% -$6.14M ﹤0.01% 1107
2016
Q4 		$20M Buy
189,953
+10,737
+6% +$1.12M 0.01% 1003
2016
Q3 		$19.8M Buy
179,216
+94,865
+112% +$12.6M 0.01% 986
2016
Q2 		$12.3M Buy
84,351
+10,118
+14% +$1.43M ﹤0.01% 1086
2016
Q1 		$10.6M Buy
74,233
+69,333
+1,415% +$9.85M ﹤0.01% 1121
2015
Q4 		$757K Hold
4,900
– – ﹤0.01% 1890
2015
Q3 		$700K Buy
+4,900
New +$685K ﹤0.01% 1899

Other funds holding TARO

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group's TARO Position: Q2 2021 in Review

Wellington Management Group sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q2 2021, closing a stake of 4,597 shares — an estimated $340K sold.

Wellington Management Group first reported a position in TARO in Q3 2015 and held it in 23 quarters. The position peaked at $20M in Q4 2016. 76 funds tracked by Wall St. Rank hold TARO as of Q2 2021.

  • Wellington Management Group reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q2 2021 after selling out during the quarter.
  • Wellington Management Group sold 4,597 Taro Pharmaceutical Industries Ltd. shares in Q2 2021, an estimated $340K.
  • Wellington Management Group first reported a position in Taro Pharmaceutical Industries Ltd. in Q3 2015 and held it in 23 quarters.
  • Wellington Management Group's Taro Pharmaceutical Industries Ltd. position peaked at $20M in Q4 2016.
  • 76 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q2 2021.

Based on Wellington Management Group's 13F filing for Q2 2021, filed 16 Aug 2021.